Although moderate-to-severe plaque psoriasis is one of the most common skin diseases worldwide, many people are still unaware of what it is, and more importantly, how devastating it is to those who suffer from it. We learn more about an exciting treatment for moderate-to-severe plaque psoriasis. It's a quarterly dosed biologic, so patients are now experiencing clearer skin with fewer doses. We're joined by a very inspiring doctor-patient duo who explain more about ILUMYA ® (tildrakizumab) , a treatment for moderate-to-severe plaque psoriasis patients. ilumya.com / psoriasis.org IMPORTANT SAFETY INFORMATION ILUMYA ® (tildrakizumab-asmn) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light). What is the most important information I should know about ILUMYA? Do not use ILUMYA if you have had a severe allergic reaction to ILUMYA or a
